Methods and compositions for thrombolytic therapy
US4968494A · kind A · utility
11Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 10, 1990 |
| Grant date | Nov 6, 1990 |
| Priority date | — |
| Expiry date | Apr 10, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/49
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Certain Factor XIIIa inhibitor compounds have been discovered which have been found to be useful in the lysis of blood clots and thus adaptable for administration in thrombolytic therapy either alone or together with plasminogen activator.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.